SORAFENIB
Treatment of hepatocellular & advanced renal cell carcinoma.
400mg bid. May be reduced to 400mg once daily if necessary.
Known hypersensitivity to sorafenib.
Dermatological toxicities, Hypertension, hemorrhage, wound healing complications cardiac ischemia, GI perforation, hepatic impairment. Pregnancy & lactation children.
Hypertension, Fatigue, Skin reactions, Diarrhea, acne, skin desquamation. Arthralgia, Myalgia. Erectile dysfunction. Thrombocytopenia, Lymphopenia and anemia. pain including mouth, abdominal & bone, asthenia, fever, flu-like illness, decreased weight.
CYP3A4 inducers (eg, carbamazepine, dexamethasone, phenobarbital, rifampin), Sorafenib plasma levels may be reduced. Bupropion, Docetaxel, Doxorubicin, Irinotecan, Fluorouracil, Warfarin.